HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Rotavirus Vaccine

The Rotavirus Vaccine is a critical tool in the prevention of rotavirus infections, which are a leading cause of severe diarrhea and dehydration in infants and young children worldwide. Rotavirus is highly contagious and spreads through the fecal-oral route, making it particularly challenging to control. The vaccine helps to protect against rotavirus by stimulating the immune system to produce antibodies that target the virus. There are two main types of rotavirus vaccines available: the oral live attenuated vaccine and the oral inactivated vaccine. Both types of vaccines are administered orally and have been shown to be safe and effective in preventing rotavirus infections.

The live attenuated rotavirus vaccine is administered in two or three doses, depending on the vaccine formulation, typically starting at around 6 to 8 weeks of age. This vaccine contains weakened forms of the rotavirus strains that are most commonly associated with severe illness. When administered, the vaccine stimulates the immune system to produce a protective response against these strains, reducing the risk of rotavirus infection and its complications. The inactivated rotavirus vaccine is administered in two doses, typically starting at around 2 to 6 months of age. This vaccine contains killed rotavirus strains and is administered orally in a liquid form. Similar to the live attenuated vaccine, the inactivated vaccine stimulates the immune system to produce antibodies against rotavirus, providing protection against infection.

Both types of rotavirus vaccines have been shown to be highly effective in preventing severe rotavirus gastroenteritis and reducing hospitalizations and deaths associated with rotavirus infection. Vaccination with the rotavirus vaccine has led to significant declines in the incidence of rotavirus-related hospitalizations and deaths in countries where it has been introduced into routine immunization programs. The rotavirus vaccine is typically recommended as part of routine childhood immunization schedules in many countries around the world. It is considered safe and well-tolerated, with the most common side effects being mild and temporary, such as fever or mild diarrhea.

Committee Members
Speaker at International Vaccines Congress 2025 - Khursheed Anwer

Khursheed Anwer

IMUNON, United States
Speaker at International Vaccines Congress 2025 - Regina Au

Regina Au

BioMarketing Insight, United States
Speaker at International Vaccines Congress 2025 - Madhu Khanna

Madhu Khanna

University of Delhi, India
IVC 2025 Speakers
Speaker at International Vaccines Congress 2025 - Khursheed Anwer

Khursheed Anwer

IMUNON, United States
Speaker at International Vaccines Congress 2025 - Regina Au

Regina Au

BioMarketing Insight, United States
Speaker at International Vaccines Congress 2025 - Madhu Khanna

Madhu Khanna

University of Delhi, India
Speaker at International Vaccines Congress 2025 - Lara Isis Teodoro

Lara Isis Teodoro

Mayo Clinic, United States
Speaker at International Vaccines Congress 2025 - Ahmed Abdulazeez

Ahmed Abdulazeez

BHRUT Trust, United Kingdom
Speaker at International Vaccines Congress 2025 - Elena Chiappini

Elena Chiappini

University of Florence, Italy

Submit your abstract Today

Watsapp